152 related articles for article (PubMed ID: 37888158)
1. Nanostructured Porous Silicon for Bone Tissue Engineering: Kinetics of Particle Degradation and Si-Controlled Release.
Fatima N; Salehi H; Cueto-Díaz EJ; Desoutter A; Cuisinier F; Cunin F; Collart-Dutilleul PY
J Funct Biomater; 2023 Sep; 14(10):. PubMed ID: 37888158
[TBL] [Abstract][Full Text] [Related]
2. Allogenic Stem Cells Carried by Porous Silicon Scaffolds for Active Bone Regeneration In Vivo.
Renaud M; Bousquet P; Macias G; Rochefort GY; Durand JO; Marsal LF; Cuisinier F; Cunin F; Collart-Dutilleul PY
Bioengineering (Basel); 2023 Jul; 10(7):. PubMed ID: 37508879
[TBL] [Abstract][Full Text] [Related]
3. Advanced bioceramic composite for bone tissue engineering: design principles and structure-bioactivity relationship.
El-Ghannam AR
J Biomed Mater Res A; 2004 Jun; 69(3):490-501. PubMed ID: 15127396
[TBL] [Abstract][Full Text] [Related]
4. Controlled drug delivery from composites of nanostructured porous silicon and poly(L-lactide).
McInnes SJ; Irani Y; Williams KA; Voelcker NH
Nanomedicine (Lond); 2012 Jul; 7(7):995-1016. PubMed ID: 22394185
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured porous silicon: the winding road from photonics to cell scaffolds - a review.
Hernández-Montelongo J; Muñoz-Noval A; García-Ruíz JP; Torres-Costa V; Martín-Palma RJ; Manso-Silván M
Front Bioeng Biotechnol; 2015; 3():60. PubMed ID: 26029688
[TBL] [Abstract][Full Text] [Related]
6. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.
Nieto A; Hou H; Moon SW; Sailor MJ; Freeman WR; Cheng L
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1070-80. PubMed ID: 25613937
[TBL] [Abstract][Full Text] [Related]
7. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
Hou H; Nieto A; Ma F; Freeman WR; Sailor MJ; Cheng L
J Control Release; 2014 Mar; 178():46-54. PubMed ID: 24424270
[TBL] [Abstract][Full Text] [Related]
8. Porous silicon confers bioactivity to polycaprolactone composites in vitro.
Henstock JR; Ruktanonchai UR; Canham LT; Anderson SI
J Mater Sci Mater Med; 2014 Apr; 25(4):1087-97. PubMed ID: 24398914
[TBL] [Abstract][Full Text] [Related]
9. Controlling and Predicting the Dissolution Kinetics of Thermally Oxidised Mesoporous Silicon Particles: Towards Improved Drug Delivery.
Wang F; Barnes TJ; Prestidge CA
Pharmaceutics; 2019 Nov; 11(12):. PubMed ID: 31795166
[TBL] [Abstract][Full Text] [Related]
10. Adhesion and proliferation of human mesenchymal stem cells from dental pulp on porous silicon scaffolds.
Collart-Dutilleul PY; Secret E; Panayotov I; Deville de Périère D; Martín-Palma RJ; Torres-Costa V; Martin M; Gergely C; Durand JO; Cunin F; Cuisinier FJ
ACS Appl Mater Interfaces; 2014 Feb; 6(3):1719-28. PubMed ID: 24428409
[TBL] [Abstract][Full Text] [Related]
11. Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.
Tzur-Balter A; Gilert A; Massad-Ivanir N; Segal E
Acta Biomater; 2013 Apr; 9(4):6208-17. PubMed ID: 23274152
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of mesoporous silicon/polycaprolactone composites as ophthalmic implants.
Kashanian S; Harding F; Irani Y; Klebe S; Marshall K; Loni A; Canham L; Fan D; Williams KA; Voelcker NH; Coffer JL
Acta Biomater; 2010 Sep; 6(9):3566-72. PubMed ID: 20350620
[TBL] [Abstract][Full Text] [Related]
13. Porous silicon-poly(ε-caprolactone) film composites: evaluation of drug release and degradation behavior.
Bodiford NK; McInnes SJP; Voelcker NH; Coffer JL
Biomed Microdevices; 2018 Aug; 20(3):71. PubMed ID: 30097808
[TBL] [Abstract][Full Text] [Related]
14. A bioactive metallurgical grade porous silicon-polytetrafluoroethylene sheet for guided bone regeneration applications.
Chadwick EG; Clarkin OM; Raghavendra R; Tanner DA
Biomed Mater Eng; 2014; 24(3):1563-74. PubMed ID: 24840195
[TBL] [Abstract][Full Text] [Related]
15. Enhanced bone tissue regeneration with hydrogel-based scaffolds by embedding parathyroid hormone in mesoporous bioactive glass.
Sordi MB; Fredel MC; da Cruz ACC; Sharpe PT; de Souza Magini R
Clin Oral Investig; 2023 Jan; 27(1):125-137. PubMed ID: 36018448
[TBL] [Abstract][Full Text] [Related]
16. Cyclosilicate nanocomposite: a novel resorbable bioactive tissue engineering scaffold for BMP and bone-marrow cell delivery.
El-Ghannam A; Ning CQ; Mehta J
J Biomed Mater Res A; 2004 Dec; 71(3):377-90. PubMed ID: 15470721
[TBL] [Abstract][Full Text] [Related]
17. Oxidation-Induced Trapping of Drugs in Porous Silicon Microparticles.
Fry NL; Boss GR; Sailor MJ
Chem Mater; 2014 Apr; 26(8):2758-2764. PubMed ID: 25678746
[TBL] [Abstract][Full Text] [Related]
18. A novel pressed porous silicon-polycaprolactone composite as a dual-purpose implant for the delivery of cells and drugs to the eye.
Irani YD; Tian Y; Wang M; Klebe S; McInnes SJ; Voelcker NH; Coffer JL; Williams KA
Exp Eye Res; 2015 Oct; 139():123-31. PubMed ID: 26277579
[TBL] [Abstract][Full Text] [Related]
19. Dissolution kinetics of a Si-rich nanocomposite and its effect on osteoblast gene expression.
Gupta G; Kirakodu S; El-Ghannam A
J Biomed Mater Res A; 2007 Feb; 80(2):486-96. PubMed ID: 17019725
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional porous silicon for therapeutic drug delivery and imaging.
Santos HA; Bimbo LM; Lehto VP; Airaksinen AJ; Salonen J; Hirvonen J
Curr Drug Discov Technol; 2011 Sep; 8(3):228-49. PubMed ID: 21291407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
